Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream ...
The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.
New Study Finds Limited Value From Nearly One-Third of Clinical Trial Procedures and Associated Data, Highlighting Opportunity for More Patient-Centric Trial Design PHILADELPHIA, Sept. 15, 2025 ...
Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the ...
CERo Therapeutics (CERO) dosed the third patient in the starting dose cohort of its Phase 1 clinical trial evaluating CER-1236 in acute myeloid ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...
OKYO Pharma has announced its plans for the next stage of clinical development of urcosimod (formerly OK-101), its lead drug ...
A new randomized clinical trial published in JAMA Network Open provides evidence that could help influence Medicare’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback